RSS Feeds by Section
Article ID: 719401 Leukemia Drug Shows Promise for Treating a Childhood Brain CancerUniversity of California San Diego HealthSkaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego researchers describe new use of leukemia drug, nilotinib, to treat subtype of medulloblastoma, a deadly pediatric brain cancer. Released:20-Sep-2019 4:20 PM EDTResearch Results
Channels: Blood, Cancer, Children's Health, Pharmaceuticals, PLOS ONE, Languages: Cancer, Pediatrics, Cell Biology, Pediatric Cancer, Pharmaceutical Sciences, drug repurposing, Medulloblastoma, Neurology |
 Article ID: 719362 Long-Acting Injectable Multi-Drug Implant Shows Promise for HIV Prevention and TreatmentUniversity of North Carolina School of MedicineA new study published today in Nature Communications shows a promising alternative for those who have to take a daily pill regimen. Released:20-Sep-2019 12:05 PM EDTResearch Results
Channels: AIDS and HIV, All Journal News, Immunology, Infectious Diseases, Pharmaceuticals, Public Health, Nature (journal), Languages: HIV, AIDS, Hiv Prevention, Hiv Treatment, Injectable, injectable drugs, Implant, Long-acting , drug delivery implant, Drug Delivery, Biodegradable |
Article ID: 719178 Open Medicare Data Helps Uncover Potential Hidden Costs of Health CareIndiana UniversityIU scientists studying Medicare data have found an association between health care industry payments to medical providers for non-research expenses and what these providers charge for medical services. Released:18-Sep-2019 10:35 AM EDTLaw and Public Policy Research Results
Channels: All Journal News, Healthcare, Pharmaceuticals, Nature (journal), Embargoed Feed - hidden, Languages: Healthcare Industry, Medical Bills, healthcare cost, Health Care Cost, health care industry, Conflict Of Interest, Health Care, Healthcare, Cost of Health Care, cost of healthcare |
Article ID: 719306 حصول Mayo Clinic على اعتماد إدارة الغذاء والدواء الأمريكية (FDA) لمنشأة تصوير متطور للكشف عن السرطانMayo Clinicاعتمدت إدارة الغذاء والدواء الأمريكية استخدام منشأة الكمياء الإشعاعية للتصوير المقطعي بالإصدار البوزيتروني، والتي تُعرَف أيضًا باسم منشأة سيكلوترون، في Mayo Clinic بفلوريدا. Released:19-Sep-2019 3:05 PM EDTResearch Results
Channels: Healthcare, Heart Disease, Pharmaceuticals, Languages: Mayo Clinic, السيكلوترون جهاز لتحطيم نوى الذرات, سرطان, الطب النووي |
Article ID: 719282 How to Taper Off Opioid Medications SafelyOhio State University Wexner Medical CenterWhitney Luke, MD, a board certified pain medicine and addiction medicine specialist at The Ohio State University Wexner Medical Center, explains how to properly taper opioid medication. Released:19-Sep-2019 12:05 PM EDT
EXPERT AVAILABLE
Feature Expert
Channels: Addiction, Drugs and Drug Abuse, Pain, Pharmaceuticals, Substance Abuse, Languages: Addiction, Opioids, Opioid Tapering, opioid abuse prevention, Pain Medication, Pain Management |
 Article ID: 719188 Getting New Medical Treatments to Patients Can be Harder Than Landing on MarsGeorgia Institute of TechnologyIt takes about 10 years and $100 million to get a new medical device to market - $1 billion for a new drug. Most new solutions fail. The biggest foils are not the science or pre-clinical trials but the lack of finances, market miscalculation, bad business models, and regulatory snags. They can all be overcome. Released:18-Sep-2019 11:40 AM EDT
EXPERT AVAILABLE
Feature Expert
Channels: Entrepreneurship, Healthcare, Pharmaceuticals, Languages: Healthcare Costs, Healthcare, Medicine, Drugs, Pharma, Pharmaceticals, pharmaceutical business, Pharmaceutical Biotechnology, pharmaceutical and healthcare business , Translational Medicine, translational medical research, Drug Development, drug developers, Medical Device, medical device companies, Angel Investor, angel investing, Venture Capital, Venture C |
|
Article ID: 719190 Investigadores de Mayo demuestran reducción de carga de células senescentes en los humanos con fármacos senolíticosMayo ClinicEn un pequeño ensayo clínico sobre seguridad y factibilidad, los investigadores de Mayo Clinic por vez primera demostraron que es posible extraer del cuerpo a las células senescentes con los fármacos llamados “senolíticos”. El resultado se verificó no solamente con análisis de sangre, sino también con el cambio en la abundancia de células senescentes en la piel y el tejido graso. Los resultados se publican en la revista EBioMedicine. Released:18-Sep-2019 11:30 AM EDTResearch Results
Channels: All Journal News, Cancer, Cell Biology, Pharmaceuticals, Languages: Mayo Clinic, envejecimiento, células senescentes, Senolíticos |
 Article ID: 719191 Taking Baby Aspirin Improves Overall Survival for Patients With Head & Neck, Lung CancerRoswell Park Comprehensive Cancer CenterIn companion presentations at the American Society for Therapeutic Radiation Oncology Annual Meeting, doctors from Roswell Park Comprehensive Cancer Center report new evidence that low-dose aspirin and other anti-inflammatories may improve survival in patients with some head/neck and lung cancers. Released:18-Sep-2019 11:05 AM EDTResearch Results
Channels: Cancer, Pharmaceuticals, Cancer Center Featured Story 2, Medical Meetings, Languages: Aspirin, Nsaids, Radiation Therapy, Radiotherapy, Cancer Treatment, Cancer Research |
 Article ID: 719166 MicroRNA-based Therapy May be New Weapon to Combat CancerStony Brook UniversityA technology that manipulates microRNAs (miRNAs) developed by Jingfang Ju, PhD, a biochemist and Professor in the Department of Pathology at the Renaissance School of Medicine at Stony Brook University, and colleagues has shown promise when used as anti-cancer therapeutic. Released:18-Sep-2019 9:05 AM EDT |
